Global Radix Paeoniae Alba Extract Market was valued at US $ 0.9 Billion in 2022 and is expected to reach US $ 1.2 Billion by 2030 growing at a CAGR of 4.1% during the forecast period 2023 – 2030.
The Radix Paeoniae Alba (RPA) extract market encompasses a diverse and dynamic sector dedicated to the production, distribution, and sale of products derived from the roots of the Paeonia lactiflora plant, commonly known as white peony or Chinese peony. RPA extract, obtained through various extraction processes, is renowned for its potential health benefits, including anti-inflammatory and antioxidant properties. This market caters to a wide array of consumer needs and preferences, offering a rich variety of products, ranging from dietary supplements to herbal remedies and skincare formulations. Consumer interest in natural and herbal alternatives to synthetic pharmaceuticals has been a driving force behind the market's growth. 

RPA extract is positioned as a natural solution that aligns with holistic approaches to health and wellness. Recognized for its potential health advantages, it has found a place in various health-related products. Regulatory compliance and adherence to quality standards are essential considerations for businesses operating within this market to ensure the safety and effectiveness of their offerings.

Global accessibility is a hallmark of the RPA extract market, with products readily available to consumers through diverse distribution channels, including traditional retail outlets, e-commerce platforms, and healthcare providers. Scientific research plays a pivotal role in advancing our understanding of RPA extract's health benefits and potential applications, driving innovation within the market.

Some of the benefits of designing a Radix Paeoniae Alba Extract Market include:

Promoting Wellbeing: RPA extract is recognized for its potential to promote wellbeing, thanks to its anti-inflammatory and antioxidant properties. Consumers have the option to incorporate RPA extract-containing products into their lifestyles to support their overall health and vitality.

Natural Healing Alternative: RPA extract serves as a natural and herbal alternative to synthetic pharmaceuticals. It caters to the growing preference among consumers for natural remedies, aligning with the trend towards holistic health and wellness.

Product Diversity: Within the market, a wide array of product options is available, ranging from dietary supplements to skincare formulations and herbal solutions. This diverse product landscape empowers consumers to select offerings that precisely match their unique requirements and preferences.

Enhanced Immunity: With increasing global health concerns, RPA extract is positioned as a potential ally in fortifying the immune system. This becomes particularly significant during events like the COVID-19 pandemic, as individuals seek strategies to bolster their immunity.

Catalyst for Innovation: The market acts as a catalyst for innovation and scientific exploration. Companies have the opportunity to delve into uncharted territories, uncovering new applications and health advantages associated with RPA extract. This drive for innovation fuels the development of groundbreaking products and formulations.

COVID -19 Impact 

The Radix Paeoniae Alba (RPA) extract market experienced a dynamic shift in response to the COVID-19 pandemic, with distinct impacts before, during, and potentially after the crisis. Prior to the pandemic, the market was on a growth trajectory, driven by rising consumer interest in natural and herbal products. Innovation and research efforts were expanding the range of applications for RPA extract in dietary supplements, skincare formulations, and other health-related products.

During the COVID-19 pandemic, the market encountered a mixed landscape. Supply chain disruptions in the early stages disrupted sourcing and distribution, challenging the industry. However, the increased focus on health and wellness prompted a surge in demand for herbal supplements, including those containing RPA extract. Consumers sought natural solutions to support their immune systems and overall well-being. E-commerce platforms emerged as vital channels for product distribution as lockdowns and restrictions limited physical retail access. Concurrently, regulatory agencies imposed stricter scrutiny on health claims associated with herbal products, adding compliance challenges for market players.

Looking ahead, the RPA extract market may continue to benefit from sustained consumer interest in health and wellness. E-commerce is expected to maintain its dominance, reflecting the changing shopping habits of consumers. The emphasis on immunity-boosting products and the natural health benefits of RPA extract may persist. Companies are likely to focus on research and innovation to uncover new applications and health benefits. Navigating evolving regulatory requirements will remain a priority, ensuring accurate marketing and labeling of RPA extract-based products. It's crucial to consult updated market reports and information to gain a current understanding of the RPA extract market's post-pandemic landscape.

Factors Driving the Market

Drivers

Growing demand for herbal supplements and natural products

The Radix Paeoniae Alba (RPA) extract market is experiencing robust growth, driven by the surging demand for herbal supplements and natural products. In an era marked by a heightened focus on health and wellness, consumers are increasingly turning to herbal supplements as a natural and holistic approach to maintaining well-being. The perceived safety and minimal risk of adverse reactions associated with natural ingredients, such as RPA extract, make them an attractive choice for health-conscious individuals. Cultural and traditional influences play a pivotal role, as many societies have a deep-rooted history of utilizing herbal remedies. This familiarity and trust in herbal solutions contribute to their growing popularity. Furthermore, the shift towards preventive healthcare practices has spurred interest in herbal supplements as proactive tools for health maintenance.

The dissemination of information through digital platforms has empowered consumers with knowledge about the benefits of herbal products, further fueling demand. RPA extract, derived from the peony plant's roots, aligns with the preference for plant-based solutions and sustainability, making it an appealing choice for environmentally conscious consumers. Herbal supplements are an integral part of the holistic health movement, acknowledging the interdependence of physical, mental, and emotional well-being. Regulatory support and safety standards in many regions bolster consumer confidence in the quality and efficacy of herbal supplements. Manufacturers, recognizing this growing trend, are diversifying their product offerings to cater to various consumer needs and preferences.

Challenges

Lack of awareness about the health benefits of RPA extract

The lack of awareness about the health benefits of Radix Paeoniae Alba (RPA) extract can significantly impede the growth of the market. This dearth of understanding directly translates into limited consumer demand, as potential users remain unaware of the advantages offered by RPA extract. Consequently, the adoption of products containing RPA extract may stagnate, as consumers may opt for more familiar alternatives instead. This lack of awareness also translates into missed opportunities for market growth, with companies manufacturing RPA extract-based products potentially missing out on a substantial consumer base.

Moreover, overcoming this hurdle requires additional investments in educational initiatives, aimed at enlightening consumers about the benefits of RPA extract. Such endeavors often entail increased marketing costs and slower market penetration. In a competitive landscape, companies that effectively communicate the health benefits of their RPA extract-based products enjoy a distinct advantage, leaving those without well-informed consumers at a disadvantage. Additionally, the limited awareness can hinder regulatory acceptance, as authorities may require substantial scientific evidence of health benefits before approving specific health claims on product labels. Consequently, the process of building this evidence and gaining regulatory approval may proceed at a slower pace. This lack of awareness can also lead to limited investment in research and development, as companies and researchers may be less inclined to explore the potential health benefits of RPA extract in the absence of significant market demand.

Trends

Expansion into new markets

Expansion into new markets is a pivotal driver of growth in the Radix Paeoniae Alba (RPA) extract market, offering a multitude of benefits for businesses operating in this sector. One of the primary advantages is diversification. By venturing into previously untapped geographical regions or exploring new consumer segments, companies can diversify their customer base and revenue streams. This diversification reduces the risk associated with dependence on a single market, providing a more stable foundation for sustained growth.

Increased sales are a natural outcome of market expansion. Companies entering new markets can leverage fresh growth opportunities, resulting in higher sales volumes and increased revenue. This is particularly significant in mature markets where growth prospects may be limited due to saturation. The exploration of new markets injects vitality into a business's growth trajectory. Moreover, market expansion can substantially enhance brand recognition and reputation. As a company introduces its products or services to a new audience, it often enjoys a halo effect that positively impacts its brand image. The strengthened brand recognition can transcend borders, benefiting sales in both new and existing markets. Economies of scale also come into play when a business expands into new markets. As sales volumes increase, production costs per unit may decrease, leading to improved profit margins. This cost-effectiveness can enhance a company's competitive position in all markets it serves.

Furthermore, market expansion offers a strategic advantage by positioning a company ahead of competitors. Businesses that establish a robust presence in multiple markets tend to enjoy a stronger market position and greater negotiating power. Access to valuable resources is another valuable outcome of market expansion. New markets may provide access to essential resources such as raw materials, skilled labor, or strategic partners, further bolstering a company's production capabilities and competitiveness. Ultimately, market expansion diversifies risks, spreads business risks across various regions, and insulates a company from the potential impact of economic, political, or regulatory changes in any single market. This strategic diversification of risk contributes to the long-term resilience and growth potential of businesses in the RPA extract market.

Market Segmentation 

By Type

• The Medical dominated the Radix Paeoniae Alba Extract Market in
• The Industrial is the fastest growing segment, growing at a CAGR of 4.8% during the forecast period.

By Type, the global Radix Paeoniae Alba Extract Market is divided into Medical Grade, Industrial Grade.

In the Radix Paeoniae Alba (RPA) extract market, the dichotomy between medical and industrial grades is evident. Medical grade RPA extracts take the lead, primarily due to their well-earned clinical credibility, regulatory approvals, and prescription-based distribution. These factors provide a foundation of trust among healthcare professionals and patients alike, ensuring a consistent and predictable demand for their use in specific therapeutic contexts.

Conversely, the industrial grade RPA extract segment is experiencing a remarkable surge in growth. This expansion is driven by shifting consumer preferences towards holistic health and wellness, prompting an increasing inclination towards natural and plant-based supplements. The accessibility of industrial grade products over the counter appeals to a broader consumer base seeking preventive health measures. These extracts find diverse applications, from dietary supplements to cosmetics, and their adaptability to various consumer needs and market trends is further accelerated by relatively lenient regulatory requirements compared to their medical grade counterparts.

By Application

• The Pharmaceutical segment dominated the Radix Paeoniae Alba Extract market in 2022.
• Nutraceuticals is the fastest growing segment, growing at a CAGR of 5.2% during the forecast period.

By Application the Radix Paeoniae Alba Extract Market is divided by Pharmaceuticals, Nutraceuticals, Cosmetics, Food and beverages.

In the Radix Paeoniae Alba (RPA) extract market, the pharmaceutical and nutraceutical segments exhibit distinct dynamics, with pharmaceuticals traditionally leading the way and nutraceuticals emerging as the fastest-growing sector. Pharmaceutical applications of RPA extract have long held prominence, primarily owing to their well-established use in medicinal contexts, backed by extensive research and regulatory approvals for specific therapeutic purposes. These pharmaceutical products are often prescribed by healthcare professionals, ensuring a steady and predictable demand. Conversely, the nutraceutical segment is experiencing remarkable growth due to evolving consumer preferences and a shifting focus towards holistic health and wellness. 

Consumers increasingly favor natural and plant-based supplements, propelling the demand for RPA extract in this category. Nutraceuticals are often associated with preventive health measures and are available over the counter, making them readily accessible and convenient for a broader consumer base. The global wellness industry's expansion further fuels the growth of nutraceuticals, which offer a diverse portfolio of dietary supplements and functional foods containing RPA extract to cater to a variety of health needs and preferences. With less stringent regulatory requirements compared to pharmaceuticals, nutraceuticals can swiftly adapt to market trends and consumer demands, contributing to their rapid ascent in the RPA extract market.

By Region

• The APAC region dominated the Radix Paeoniae Alba Extract market in 2022.
• The APAC region is the fastest growing segment, growing at a CAGR of 4.7% during the forecast period.

By region, the global Radix Paeoniae Alba Extract Market is divided into North America, Europe, APAC and Others. Others is further divided into Middle East, Africa and South America.

The Asia-Pacific (APAC) region has emerged as a leader and a hotbed of rapid growth in the Radix Paeoniae Alba (RPA) extract market, primarily due to a confluence of factors. First and foremost, the rich history of traditional herbal medicine deeply rooted in APAC cultures has significantly contributed to the prominence of herbal extracts. With traditional systems like Traditional Chinese Medicine (TCM), Ayurveda, and Kampo medicine valuing the therapeutic potential of RPA extract, demand has steadily risen. Cultural and regional preferences in the APAC region favor natural and herbal remedies, aligning with the global trend towards holistic wellness. 

This preference for natural products, steeped in ancient traditions, has played a pivotal role in driving the RPA extract market's growth. Furthermore, the heightened health awareness prevalent in the APAC region has spurred interest in plant-based and herbal solutions, as consumers increasingly seek alternatives to synthetic pharmaceuticals. With an expanding middle-class population boasting greater disposable income, there is a growing willingness to invest in health and wellness products, including herbal extracts. The APAC region has also seen considerable investments in research and innovation within the herbal medicine sector. This has led to the development of standardized extracts and improved product quality, bolstering consumer confidence and attracting the attention of pharmaceutical companies.

Competitive Landscape

The global Radix Paeoniae Alba Extract Market is consolidated with the presence of few major players contributing to the market revenue. This dominance of these major players is driven by their technological expertise, extensive resources, and established brand recognition. These companies typically offered comprehensive and diversified solutions to end use industries.

• Layn Natural Ingredients

Layn Natural Ingredients is a global leader in the production and innovation of premium plant-based functional ingredients. The company was founded in 1995 and is headquartered in Guilin, China. Layn has a global presence, with offices and sales representatives in over 20 countries. Layn specializes in the production of high-quality plant-based extracts, including monk fruit extract, steviol glycoside, and Radix Paeoniae Alba extract. The company also produces a variety of other plant-based ingredients, such as natural colors, flavors, and antioxidants.

• SanYuanTianYu Biological Products

SanYuanTianYu Biological Products Co., Ltd. is a Chinese company that specializes in the production of biological products, including Radix Paeoniae Alba (RPA) extract. The company was founded in 2010 and is headquartered in Sanyuan County, Shaanxi Province, China. SanYuanTianYu Biological Products has a state-of-the-art production facility that is equipped with the latest technologies and equipment. The company also has a team of experienced and qualified scientists and engineers who are responsible for the development and production of its products.

• Wuhan Dongkangyuan Technology Co. Ltd.

Wuhan Dongkangyuan Technology Co. Ltd. is a Chinese company that specializes in the production of Radix Paeoniae Alba (RPA) extract. The company was founded in 2008 and is headquartered in Wuhan, Hubei Province, China. Wuhan Dongkangyuan Technology Co. Ltd. has a state-of-the-art production facility that is equipped with the latest technologies and equipment. The company also has a team of experienced and qualified scientists and engineers who are responsible for the development and production of its products.

• Shaanxi XingTianYu Biotech
• Xi 'an Kangwei BioEngineering Co. LTD
• Guanghan Bencaozhihua Limited
• Shaanxi Taiji Pharmaceutical Co., Ltd.
• Zhejiang Tianyu Pharmaceutical Co., Ltd
• Shaanxi Baoji Huasheng Pharmaceutical Co., Ltd.
• Shaanxi Kangtai Pharmaceutical Co., Ltd.
• Shaanxi Kangyuan Pharmaceutical Co., Ltd.
• Shaanxi Kehua Pharmaceutical Co., Ltd.
• Shaanxi Tianyu Pharmaceutical Co., Ltd.
• Shaanxi Weikang Pharmaceutical Co., Ltd
• Shaanxi Xintai Pharmaceutical Co., Ltd.
• Shaanxi Yulin Pharmaceutical Co., Ltd.
• Shaanxi Zhengtai Pharmaceutical Co., Ltd.
• Shandong Tianyu Pharmaceutical Co., Ltd.
• Sichuan Tianyu Pharmaceutical Co., Ltd. 
• Tianjin Tianyu Pharmaceutical Co., Ltd.
• Xinjiang Tianyu Pharmaceutical Co., Ltd.
• Yunnan Tianyu Pharmaceutical Co., Ltd.

Recent Developments

• In 2023, Shaanxi Taiji Pharmaceutical Co., Ltd., a leading manufacturer of RPA extract in China, recently announced a partnership with a leading research institute to study the health benefits of RPA extract in preventing and managing chronic diseases, such as cardiovascular disease, diabetes, and cancer. The partnership is expected to generate new scientific evidence on the health benefits of RPA extract and support the development of new RPA extract-based products for the prevention and management of chronic diseases.

Radix Paeoniae Alba Extract Market Scope

Table of Contents

1 INTRODUCTION OF GLOBAL RADIX PAEONIAE ALBA EXTRACT MARKET

1.1 Overview of the Market

1.2 Scope of Report

1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY 

3.1 Data Mining

3.2 Validation

3.3 Primary Interviews

3.4 List of Data Sources

4 GLOBAL RADIX PAEONIAE ALBA EXTRACT MARKET OUTLOOK

4.1 Overview

4.2 Market Dynamics

4.2.1 Drivers

4.2.2 Restraints

4.2.3 Opportunities

4.3 Porters Five Force Model

4.3.1. Bargaining Power of Suppliers

4.3.2. Threat of New Entrants

4.3.3. Threat of Substitutes

4.3.4. Competitive Rivalry

4.3.5. Bargaining Power among Buyers

4.4 Value Chain Analysis

5 GLOBAL RADIX PAEONIAE ALBA EXTRACT MARKET, BY TYPE

5.1 Overview

5.2 Medical Grade

5.3 Industrial Grade

6 GLOBAL RADIX PAEONIAE ALBA EXTRACT MARKET, BY APPLICATION

6.1 Overview

6.2 Pharmaceuticals

6.3 Nutraceuticals

6.4 Cosmetics

6.5 Food and beverages

7 GLOBAL RADIX PAEONIAE ALBA EXTRACT MARKET, BY REGION

7.1 North America

7.1.1 U.S.

7.1.2 Canada

7.2 Europe

7.2.1 Germany

7.2.3 U.K.

7.2.4 France

7.2.5 Rest of Europe

7.3 Asia Pacific

7.3.1 China

7.3.2 Japan

7.3.3 India

7.3.4 South Korea

7.3.5 Singapore

7.3.6 Malaysia

7.3.7 Australia

7.3.8 Thailand

7.3.9 Indonesia

7.3.10 Philippines

7.3.11 Rest of Asia Pacific

7.4 Others

7.4.1 Saudi Arabia

7.4.2 U.A.E.

7.4.3 South Africa

7.4.4 Egypt

7.4.5 Israel

7.4.6 Rest of Middle East and Africa (MEA)

7.4.7 Brazil

7.4.8 Argentina

7.4.9 Mexico

7.4.10 Rest of South America

8 COMPANY PROFILES

8.1 Yunnan Tianyu Pharmaceutical Co., Ltd.

8.1.1. Company Overview

8.1.2. Key Executives

8.1.3. Operating Business Segments

8.1.4. Product Portfolio

8.1.5. Financial Performance (As per availability)

8.1.6 Key News

8.2 Xinjiang Tianyu Pharmaceutical Co., Ltd.

8.2.1. Company Overview

8.2.2. Key Executives

8.2.3. Operating Business Segments

8.2.4. Product Portfolio

8.2.5. Financial Performance (As per availability)

8.2.6. Key News

8.3 Tianjin Tianyu Pharmaceutical Co., Ltd.

8.3.1. Company Overview

8.3.2. Key Executives

8.3.3. Operating Business Segments

8.3.4. Product Portfolio

8.3.5. Financial Performance (As per availability)

8.3.6. Key News

8.4  Sichuan Tianyu Pharmaceutical Co., Ltd.

8.4.1. Company Overview

8.4.2. Key Executives

8.4.3. Operating Business Segments

8.4.4. Product Portfolio

8.4.5. Financial Performance (As per availability)

8.4.6. Key News

8.5 Shandong Tianyu Pharmaceutical Co., Ltd.

8.5.1. Company Overview

8.5.2. Key Executives

8.5.3. Operating Business Segments

8.5.4. Product Portfolio

8.5.5. Financial Performance (As per availability)

8.5.6. Key News

8.6 Shaanxi Zhengtai Pharmaceutical Co., Ltd.

8.6.1. Company Overview

8.6.2. Key Executives

8.6.3. Operating Business Segments

8.6.4. Product Portfolio

8.6.5. Financial Performance (As per availability)

8.6.6. Key News

8.7 Shaanxi Yulin Pharmaceutical Co., Ltd.

8.7.1. Company Overview

8.7.2. Key Executives

8.7.3. Operating Business Segments

8.7.4. Product Portfolio

8.7.5. Financial Performance (As per availability)

8.7.6. Key News

8.8 Shaanxi Xintai Pharmaceutical Co., Ltd.

8.8.1. Company Overview

8.8.2. Key Executives

8.8.3. Operating Business Segments

8.8.4. Product Portfolio

8.8.5. Financial Performance (As per availability)

8.8.6. Key News

8.9 Shaanxi Weikang Pharmaceutical Co., Ltd.

8.9.1. Company Overview

8.9.2. Key Executives

8.9.3. Operating Business Segments

8.9.4. Product Portfolio

8.9.5. Financial Performance (As per availability)

8.9.6. Key News

8.10 Shaanxi Tianyu Pharmaceutical Co., Ltd.

8.10.1. Company Overview

8.10.2. Key Executives

8.10.3. Operating Business Segments

8.10.4. Product Portfolio

8.10.5. Financial Performance (As per availability)

8.10.6. Key News

8.11 Shaanxi Kehua Pharmaceutical Co., Ltd.

8.11.1. Company Overview

8.11.2. Key Executives

8.11.3. Operating Business Segments

8.11.4. Product Portfolio

8.11.5. Financial Performance (As per availability)

8.11.6. Key News

8.12 Layn Natural Ingredients

8.12.1. Company Overview

8.12.2. Key Executives

8.12.3. Operating Business Segments

8.12.4. Product Portfolio

8.12.5. Financial Performance (As per availability)

8.12.6. Key News

8.13 Shaanxi Kangtai Pharmaceutical Co., Ltd.

8.13.1. Company Overview

8.13.2. Key Executives

8.13.3. Operating Business Segments

8.13.4. Product Portfolio

8.13.5. Financial Performance (As per availability)

8.13.6. Key News

8.14  SanYuanTianYu Biological Products

8.14.1. Company Overview

8.14.2. Key Executives

8.14.3. Operating Business Segments

8.14.4. Product Portfolio

8.14.5. Financial Performance (As per availability)

8.14.6. Key News

8.15 Shaanxi Baoji Huasheng Pharmaceutical Co., Ltd.

8.15.1. Company Overview

8.15.2. Key Executives

8.15.3. Operating Business Segments

8.15.4. Product Portfolio

8.15.5. Financial Performance (As per availability)

8.15.6. Key News

8.16 Zhejiang Tianyu Pharmaceutical Co., Ltd.

8.16.1. Company Overview

8.16.2. Key Executives

8.16.3. Operating Business Segments

8.16.4. Product Portfolio

8.16.5. Financial Performance (As per availability)

8.16.6. Key News

8.17 Shaanxi Taiji Pharmaceutical Co., Ltd.

8.17.1. Company Overview

8.17.2. Key Executives

8.17.3. Operating Business Segments

8.17.4. Product Portfolio

8.17.5. Financial Performance (As per availability)

8.17.6. Key News

8.18 Guanghan Bencaozhihua Limited

8.18.1. Company Overview

8.18.2. Key Executives

8.18.3. Operating Business Segments

8.18.4. Product Portfolio

8.18.5. Financial Performance (As per availability)

8.18.6. Key News

8.19 Xi 'an Kangwei BioEngineering Co. LTD

8.19.1. Company Overview

8.19.2. Key Executives

8.19.3. Operating Business Segments

8.19.4. Product Portfolio

8.19.5. Financial Performance (As per availability)

8.19.6. Key News

8.20 Wuhan Dongkangyuan Technology Co. Ltd.

8.20.1. Company Overview

8.20.2. Key Executives

8.20.3. Operating Business Segments

8.20.4. Product Portfolio

8.20.5. Financial Performance (As per availability)

8.20.6. Key News

Global Radix Paeoniae Alba Extract Market Segmentation

 Radix Paeoniae Alba Extract by Type: Market Size & Forecast 2023-2030

• Medical Grade
• Industrial Grade

 Radix Paeoniae Alba Extract by End User: Market Size & Forecast 2023-2030

• Pharmaceuticals
• Nutraceuticals
• Cosmetics
• Food and beverages

 Radix Paeoniae Alba Extract by Geography: Market Size & Forecast 2023-2030

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Major Players:

• Layn Natural Ingredients
• SanYuanTianYu Biological Products
• Wuhan Dongkangyuan Technology Co. Ltd.
• Shaanxi XingTianYu Biotech
• Xi 'an Kangwei BioEngineering Co. LTD
• Guanghan Bencaozhihua Limited
• Shaanxi Taiji Pharmaceutical Co., Ltd.
• Zhejiang Tianyu Pharmaceutical Co., Ltd
• Shaanxi Baoji Huasheng Pharmaceutical Co., Ltd.
• Shaanxi Kangtai Pharmaceutical Co., Ltd.
• Shaanxi Kangyuan Pharmaceutical Co., Ltd.
• Shaanxi Kehua Pharmaceutical Co., Ltd.
• Shaanxi Tianyu Pharmaceutical Co., Ltd.
• Shaanxi Weikang Pharmaceutical Co., Ltd
• Shaanxi Xintai Pharmaceutical Co., Ltd.
• Shaanxi Yulin Pharmaceutical Co., Ltd.
• Shaanxi Zhengtai Pharmaceutical Co., Ltd.
• Shandong Tianyu Pharmaceutical Co., Ltd.
• Sichuan Tianyu Pharmaceutical Co., Ltd. 
• Tianjin Tianyu Pharmaceutical Co., Ltd.
• Xinjiang Tianyu Pharmaceutical Co., Ltd.
• Yunnan Tianyu Pharmaceutical Co., Ltd.